Study on Thrombosis Therapy in German Cancer Patients

LEO Pharma

Status: Completed

Conditions: Pulmonary Embolism; Deep Vein Thrombosis; Cancer

Treatments: Other: no intervention is being made

Study type: Observational

Funder types: Industry

Identifiers

NCT01559883

DE-Thrombose-NIS-2012

Details and patient eligibility

About

The study aims to document the flow of German patients with cancer and acute deep vein thrombosis from first visit to diagnosis and treatment, the applied diagnostic procedures, and therapy modalities.

Enrollment: 76 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patient with cancer and acute deep vein thrombosis and/or pulmonary embolism

Exclusion criteria

• life expectancy less that 6 months
• age less that 18 years

Trial design

76 participants in 1 patient group

all eligible patients

Description:

there is only 1 Cohort in which all patients participating in this NIS are included

Treatment:

Other: no intervention is being made